Buspirone metabolite structure profile using a standard liquid chromatographic-mass spectrometric protocol

Journal of Chromatography B: Biomedical Applications

Volumn 698, Issue 1-2, 1997, Pages 133-145

  Kerns, Edward H ^a   Rourick, Robyn A ^a   Volk, Kevin J ^a   Lee, Mike S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Buspirone

Indexed keywords

BUSPIRONE; DRUG METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG IDENTIFICATION; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; LIQUID CHROMATOGRAPHY; LIVER METABOLISM; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; BODY FLUIDS; BUSPIRONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MALE; MASS SPECTROMETRY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030773975     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00254-5     Document Type: Article

References (25)

1. M.S. Lee, D.J. Hook, E.H. Kerns, K.J. Volk, I.E. Rosenberg, Biol. Mass Spectrom. 22 (1993) 84.
2. E.H. Kerns, K.J. Volk, S.E. Hill, M.S. Lee, J. Nat. Prod. 57 (1994) 1391.
3. E.H. Kerns, K.J. Volk, S.E. Hill, M.S. Lee, J. Rapid Commun. Mass Spectrom. 9 (1995) 1539.
4. K.J. Volk, S.E. Klohr, R.A. Rourick, E.H. Kerns., M.S. Lee, J. Pharm. Biomed. Anal. 14 (1996) 1663.
5. R.A. Rourick, K.J. Volk, S.E. Klohr, T. Spears, E.H. Kerns, M.S. Lee, J. Pharm. Biomed. Anal. 14 (1996) 1743.
6. P. Rudewicz, K.M. Straub, Anal. Chem. 58 (1986) 2928.
7. T.J.A. Blake, I.G. Beattie, Biomed. Environ. Mass Spectrom. 18 (1989) 637.
8. G.C. DiDonato, S.J. Gaskell, in T. Matsuo, R.M. Caprioli, M.L. Gross, Y. Seyama (Editors), Biological Mass Spectrometry Present and Future, Wiley, New York, NY, 1994, p. 541.
9. T.A. Baillie, Int. J. Mass Spectrom. Ion Processes 118/119 (1992) 289.
10. D.W. Everett, T.J. Chando, G.C. DiDonato, S.M. Singhri, H.Y. Pan, S.H. Weinstein, Drug Metab. Dispos. 19 (1991) 740.
11. W.M. Muck, J.D. Henion, Biomed. Environ. Mass Spectrom. 19 (1990) 37.
12. L. Weidolf, T.R. Covey, Rapid Commun. Mass Spectrom. 6 (1992) 192.
13. A.E. Mutlib, J.T. Strupczewski, S.M. Chesson, Drug Metab. Dispos. 23 (1995) 951.
14. R.J. Perchalski, R.A. Yost, B.J. Wilder, Anal. Chem. 54 (1982) 1466.
15. R.J. Perchalski, M.S. Lee, R.A. Yost, J. Clin. Pharmacol. 26 (1986) 435.
16. M.S. Lee, R.A. Yost, R.J. Perchalski, Annu. Rep. in Med. Chem. 21 (1986) 313.
17. M.S. Lee, R.A. Yost, Biomed. Environ. Mass Spectrom. 15 (1988) 193.
18. A. Bruins, T.R. Covey, J.D. Henion, Anal. Chem. 59 (1987) 2642.
19. D.L. Temple Jr., J.P. Yevich, J.S. New, J. Clin Psychiatry 43 (1982) 4.
20. L.A. Riblet, D.P. Taylor, M.S. Eison, H.C. Stanton, J. Clin Psychiatry 43 (1982) 11.
21. R.E. Gammans, E.H. Kerns, W.W. Bullen, J. Chromatogr. 345 (1985) 285.
22. R.E. Gammans, R.E. Johnston, in G. Tunnicliff, A.S. Eison, D.P. Taylor (Editors), Buspirone: Mechanisms and Clinical Aspects, Academic Press, San Diego, CA, 1991.
23. H. Jajoo, R. Mayol, J. LaBudde, I. Blair, Drug Metab. Dispos. 17 (1989) 625.
24. H. Jajoo, R. Mayol, J. LaBudde, I. Blair, Drug Metab. Dispos. 17 (1989) 634.
25. H.K. Jajoo, I.A. Blair, L.J. Klunk, R.F. Mayol, Xenobiotica 8 (1990) 779.